Mechanistically, FTO exerted its oncogenic role in breast cancer via demethylating BCL2 Interacting Protein 3 (BNIP3) [101], a pro-apoptosis member in the Bcl-2 apoptotic protein family [102]. The gene discussed is BNIP3; the disease is breast carcinoma.